List of Idenix Pharmaceuticals patents

Patents where

Current Assignee

Name

Idenix Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7365090 Substituted phenylindoles for the treatment of HIV	Patent 7365090 was granted and assigned to Idenix Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	7365090	April 29, 2008
‌ US Patent 8193372 Phosphothiophene and phosphothiazole HCV polymerase inhibitors	Patent 8193372 was granted and assigned to Idenix Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	8193372	June 5, 2012
‌ US Patent 6875751 3′-prodrugs of 2′-deoxy-β-L-nucleosides	Patent 6875751 was granted and assigned to Idenix Pharmaceuticals on April, 2005 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	6875751	April 5, 2005
‌ US Patent 9192621 Esters and malonates of SATE prodrugs	Patent 9192621 was granted and assigned to Idenix Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	9192621	November 24, 2015
‌ US Patent 7932240 Phosphadiazine HCV polymerase inhibitors IV	Patent 7932240 was granted and assigned to Idenix Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	7932240	April 26, 2011
‌ US Patent 9109001 3′,5′-cyclic phosphoramidate prodrugs for HCV infection	Patent 9109001 was granted and assigned to Idenix Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	9109001	August 18, 2015
‌ US Patent 9403863 Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections	Patent 9403863 was granted and assigned to Idenix Pharmaceuticals on August, 2016 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	9403863	August 2, 2016
‌ US Patent 9187515 2′,4′-fluoro nucleosides for the treatment of HCV	Patent 9187515 was granted and assigned to Idenix Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	9187515	November 17, 2015
‌ US Patent 9243025 Compounds and pharmaceutical compositions for the treatment of viral infections	Patent 9243025 was granted and assigned to Idenix Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	9243025	January 26, 2016
‌ US Patent 8362068 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors	Patent 8362068 was granted and assigned to Idenix Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	8362068	January 29, 2013
‌ US Patent 6914054 Methods and compositions for treating hepatitis C virus	Patent 6914054 was granted and assigned to Idenix Pharmaceuticals on July, 2005 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	6914054	July 5, 2005
‌ US Patent 8951985 Compounds and pharmaceutical compositions for the treatment of viral infections	Patent 8951985 was granted and assigned to Idenix Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	8951985	February 10, 2015
‌ US Patent 7534809 Phospho-indoles as HIV inhibitors	Patent 7534809 was granted and assigned to Idenix Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	7534809	May 19, 2009
‌ US Patent 8993595 Macrocyclic serine protease inhibitors	Patent 8993595 was granted and assigned to Idenix Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	8993595	March 31, 2015
‌ US Patent 8486991 Enantiomerically pure phosphoindoles as HIV inhibitors	Patent 8486991 was granted and assigned to Idenix Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	8486991	July 16, 2013
‌ US Patent 10231986 Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV	Patent 10231986 was granted and assigned to Idenix Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	10231986	March 19, 2019
‌ US Patent 7960428 Enantiomerically pure phosphoindoles as HIV inhibitors	Patent 7960428 was granted and assigned to Idenix Pharmaceuticals on June, 2011 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	7960428	June 14, 2011
‌ US Patent 8377962 Macrocyclic serine protease inhibitors	Patent 8377962 was granted and assigned to Idenix Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	8377962	February 19, 2013
‌ US Patent 9249173 Compounds and pharmaceutical compositions for the treatment of viral infections	Patent 9249173 was granted and assigned to Idenix Pharmaceuticals on February, 2016 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	9249173	February 2, 2016
‌ US Patent 8481748 Phosphinate ruthenium complexes	Patent 8481748 was granted and assigned to Idenix Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	8481748	July 9, 2013
‌ US Patent 9353100 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections	Patent 9353100 was granted and assigned to Idenix Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	9353100	May 31, 2016
‌ US Patent 8507460 Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections	Patent 8507460 was granted and assigned to Idenix Pharmaceuticals on August, 2013 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	8507460	August 13, 2013
‌ US Patent 10030044 Nucleotides for the treatment of liver cancer	Patent 10030044 was granted and assigned to Idenix Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	10030044	July 24, 2018
‌ US Patent 8093379 Macrocyclic serine protease inhibitors	Patent 8093379 was granted and assigned to Idenix Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		Idenix Pharmaceuticals	United States Patent and Trademark Office	8093379	January 10, 2012
‌ US Patent 9115095 Phosphinate ruthenium complexes	Patent 9115095 was granted and assigned to Idenix Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	Idenix Pharmaceuticals	Idenix Pharmaceuticals	United States Patent and Trademark Office	9115095	August 25, 2015

Results per page:

44 results

0 selected

44 results

0 selected